person

Mirjam G. W.

Country
Germany
Department
Deaprtment of Cardiology and Angiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 7 partner sites.

Specializations

Atrial Fibrillation and Stroke Prevention

The investigator focuses on anticoagulation strategies to lower stroke and systemic embolism risk in patients with atrial fibrillation.

  • Direct oral anticoagulant efficacy
  • Bleeding safety assessment
  • Benefit‑risk optimization

This work supports more precise therapeutic decisions for rhythm disorders.

Acute Myocardial Infarction Management

Research targets rapid self‑administration of therapies to limit damage during acute myocardial infarction.

  • Early symptom‑driven treatment
  • Recurrent infarction prevention
  • Patient‑controlled intervention

These initiatives aim to improve outcomes for individuals experiencing heart attacks.

Aortic Stenosis and Valve Replacement

The investigator examines pharmacologic support, particularly beta blockers, for patients undergoing transcatheter aortic valve replacement.

  • Peri‑procedural hemodynamic stabilization
  • Post‑procedure recovery enhancement
  • Long‑term valve function preservation

This focus addresses therapeutic needs around structural heart interventions.

Lipoprotein(a)–Targeted Cardiovascular Therapy

Studies investigate agents that lower lipoprotein(a) to reduce events in patients with atherosclerotic cardiovascular disease.

  • Cardiovascular event risk reduction
  • Coronary heart disease mortality mitigation
  • Urgent revascularization prevention

The aim is to integrate lipid‑focused treatment into broader heart disease management.

Broad Cardiovascular Disease Prevention

Overall, the investigator’s portfolio spans prevention of major cardiovascular outcomes across diverse patient groups.

  • Risk stratification in high‑risk populations
  • Therapeutic innovation in thrombosis and lipid pathways
  • Integration of emerging pharmacologic agents

This comprehensive approach supports advances in cardiovascular health.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.